The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
According to AbbVie's latest financial reports the company's current EPS (TTM) is ยฃ2.91. In 2022 the company made an earnings per share (EPS) of ยฃ5.27 an increase over its 2021 EPS that were of ยฃ5.13.